Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	3.67B -	3.78B 3.08%	3.41B 9.69%	3.77B 10.35%	3.77B 0.08%	4.15B 10.03%
cost of revenue	1.31B -	1.33B 1.07%	1.28B 3.17%	1.47B 14.16%	1.52B 3.54%	1.64B 8.10%
gross profit	2.35B -	2.45B 4.21%	2.13B 13.22%	2.30B 8.04%	2.25B 2.13%	2.50B 11.34%
selling and marketing expenses		346M -	285M 17.63%	335M 17.54%	319M 4.78%
general and administrative expenses		1.04B -	968M 6.56%	1.05B 8.88%	1.16B 9.96%
selling general and administrative expenses	1.33B -	1.38B 4.14%	1.25B 9.33%	1.39B 10.85%	1.48B 6.41%	1.74B 17.46%
research and development expenses	221M -	258M 16.74%	253M 1.94%	271M 7.11%	307M 13.28%	324M 5.54%
other expenses	377M -	348M 7.69%	323M 7.18%	292M 9.60%	244M 16.44%
cost and expenses	3.24B -	3.31B 2.38%	3.11B 6.06%	3.42B 9.79%	3.55B 3.77%	3.94B 11.10%
operating expenses	1.93B -	1.99B 3.27%	1.83B 8.00%	1.95B 6.72%	2.03B 3.94%	2.30B 13.36%
interest expense	8M -				146M -	283M 93.84%
ebitda	932M -	1.00B 7.40%	750M 25.07%	785M 4.67%	457M 41.78%	601M 31.51%
operating income	416M -	532M 27.88%	260M 51.13%	329M 26.54%	207M 37.08%	130M 37.20%
depreciation and amortization	495M -	469M 5.25%	490M 4.48%	456M 6.94%	250M 45.18%	382M 52.80%
total other income expenses net	-10M -	-133M 1,230%	30M 122.56%	-11M 136.67%	-134M 1,118.18%	-102M 23.88%
income before tax	417M -	399M 4.32%	290M 27.32%	318M 9.66%	73M 77.04%	-166M 327.40%
income tax expense	-302M -	96M 131.79%	307M 219.79%	125M 59.28%	58M 53.60%	82M 41.38%
net income	710M -	298M 58.03%	-17M 105.70%	182M 1,170.59%	15M 91.76%	-260M 1,833.33%
weighted average shs out	350M -	350M 0%	350M 0%	350M 0%	350M 0%	350.50M 0.14%
weighted average shs out dil	350M -	350M 0%	350M 0%	350M 0%	350M 0%	350.50M 0.14%
eps	2.03 -	0.85 58.13%	-0.05 105.72%	0.52 1,169.96%	0.04 91.75%	-0.74 1,824.94%
epsdiluted	2.03 -	0.85 58.13%	-0.05 105.72%	0.52 1,169.96%	0.04 91.75%	-0.74 1,824.94%

NYSE:BLCO

Bausch + Lomb Corporation

Last Close

16.00

30/08 20:00

Market Cap

5.43B

Beta: -

Volume Today

245.58K

Avg: 384.32K

PE Ratio

−23.54

PFCF: −321.80

Preview